Endoscopic Innovation Differentiators
The Digestive Disease Center (DDC) at MUSC Health is comprised of nationally renowned specialists in gastroenterology and gastrointestinal surgery. These experts provide state-of-the-art diagnosis and treatment to patients with complex pancreatic and biliary disease, gastrointestinal cancer and pre-malignant conditions, esophageal disorders, inflammatory bowel diseases, liver disease, functional bowel disorders, general gastroenterology, and nutrition.
New Directions in the Endoscopic and Surgical Management of Chronic Pancreatitis
– Fall 2014 Progressnotes
The DDC's Division of Gastroenterology and Hepatology is recognized as a worldwide leader in gastrointestinal endoscopy. Innovation in endoscopy has always been one of the pillars of cutting-edge medicine at MUSC Health. In response to the retirement of Peter Cotton from clinical practice, MUSC Health has recruited gastroenterologists with national reputations for their excellence in clinical research and considerable experience in advanced endoscopy
Specialists Offering Unique Treatments
Gregory Andrew Coté, MD, MS
An Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, Dr. Gregory Coté specializes primarily in pancreatobiliary diseases and related endoscopic procedures.
Badih Joseph Elmunzer, MD, MSc
An Associate Professor of Medicine and The Peter B. Cotton Endowed Chair for Endoscopic Innovation in the Division of Gastroenterology and Hepatology, Dr. Joseph Elmunzer specializes primarily in advanced diagnostic and therapeutic endoscopy.
Brenda J. Hoffman, MD, FAGA, FASGE, FACG, FACP
A Professor of Medicine, Director of endosonography program, and Lead of the GI cancer program in the Division of Gastroenterology and Hepatology, Dr. Brenda Hoffman specializes primarily in endoscopic ultrasound and the treatment of pre-malignant lesions and early cancers of the GI tract.
The spectrum of advanced endoscopic practice at MUSC includes basic and complex ERCP, diagnostic and interventional EUS, and endoscopic treatment of premalignant lesions and early cancers of the GI tract.
Procedures Unique In The Region
- Advanced ERCP-based diagnostics for indeterminate biliary strictures, including choledochoscopy
- ERCP-directed therapy of chronic pancreatitis, including treatment of refractory bile duct strictures and pancreatic duct stones
- Endoscopic treatment of local complications of pancreatitis, including drainage of pseudocysts and debridement of walled-off pancreatic necrosis
- ERCP in patients with surgically altered anatomy
- EUS-guided biliary and pancreatic access & drainage
- Endoscopic closure of gastrointestinal luminal defects, leaks, and fistulae
- Radiofrequency ablation, cryoablation, and endoscopic mucosal resection (EMR) of complicated Barrett's esophagus
- Endoscopic resection of complex polyps throughout the GI tract
- Endoscopic submucosal dissection
- Per oral endoscopic myotomy (POEM)
- Endoscopic incisional therapy for refractory strictures, diverticula, and sinus tracts
These procedures include:
- Endoscopic submucosal dissection (ESD), which allows en bloc (in one piece) removal of gastric and colonic neoplasia. This highly specialized technique is used in only a few clinical practices in the United States.
- Endoscopic mucosal resection (EMR) for laterally-spreading complex (or defiant) colon polyps and for complicated Barrett's esophagus with high-grade dysplasia and early esophageal cancer.
- Per oral endoscopic myotomy (POEM) for the treatment of achalasia and other motility disorders of the esophagus; an alternative to surgery for selected patients.
How to Refer
Please contact the following if you have questions and/or concerns:
GI Cancer – EUS
Cindy Ferguson, RN
Panc./Biliary – ERCP
Peggy Edgerton, RN
Elaine Rawls, RN
Special Procedures: BARRX, EMR, Capsule Enteroscopy, Pneumatic-Dilation
Beth Crawford, RN